
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Wednesday, 15 February 2017
Tuesday, 7 February 2017
BioLargo’s Advanced Oxidation System (AOS) Poised to Impact $862 Billion Global Water Market
for the next century” adding,
“investors who
know how to play the
infrastructure boom
will reap huge
rewards.”
Test results show that
the AOS achieves
unprecedented rates of
disinfection, and eliminates
infectious biological
pathogens such as Salmonella
enterica, Listeria
monocytogenes and E. coli.
BioLargo continues its
mission to Make Life Better.
Biolargo Signs Veteran Water Industry Executive Mark Lambert as Strategic Advisor
By: Marketwired

Most recently Mr. Lambert served as Chief
Executive Officer of IDE Americas Inc., a world leader in water treatment
solutions specializing in the development, engineering, construction and
operation of enhanced desalination and industrial water treatment plants. Mr.
Lambert was responsible for all IDE activities in the Americas, including project
delivery methods such as Engineering Procurement & Construction, Build &
Operate, and Build Own Operate & Transfer. In addition to desalination,
under Mr. Lambert’s tenure as CEO IDE Americas activities included industrial wastewater
treatment in oil and gas, power generation, and mining.

BioLargo’s president Dennis P. Calvert
commented, “We are honored that Mark has chosen to work with us and to help
guide our company to the next level. We believe his extensive experience,
knowledge and relationships in the water industry will help propel BioLargo’s technologies
forward to commercial success.”
Mr. Lambert commented, “BioLargo’s
Advanced Oxidation System (AOS) represents a breakthrough in the cost-effective
treatment of difficult water and wastewater streams for both municipal and industrial
applications. I look forward to working with the team at BioLargo in
positioning this advanced technology for commercial success”
About BioLargo, Inc.
BioLargo, Inc. (BLGO)
makes life better by delivering sustainable technology-based products that help
solve some of the most widespread problems threatening the world's supply of
water, food, agriculture, healthcare and energy. More information can be found
about the company and its subsidiaries at www.BioLargo.com. Its subsidiary
BioLargo Water, Inc. (www.BioLargoWater.com)
showcases the Advanced Oxidation Systems, including its AOS Filter -- a product
in development specifically designed to eliminate common, troublesome, and
dangerous (toxic) contaminants in water in a fraction of the time and cost of
current technologies. It is the winner of the Technology Star award by
New Technology Magazine for its breakthrough innovation for the oil industry
and is named the Technology Innovation Leader in the water treatment market by
Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System,
which was honored with a "Top 50 Water Company for the 21st Century"
award by the Artemis Project now being commercialized under a license to
Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features
award-winning products serving the pet, equine, military supply and consumer
markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's
subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on
advanced wound care management.

Safe Harbor Statement
The statements contained herein, which are not historical,
are forward-looking statements that are subject to risks and uncertainties that
could cause actual results to differ materially from those expressed in the
forward-looking statements, including, but not limited to, the risks and
uncertainties included in BioLargo's current and future filings with the
Securities and Exchange Commission, including those set forth in BioLargo's
Annual Report on Form 10-K.
Subscribe to:
Posts (Atom)